Chongqing Lummy Pharma: Seizing New Reimbursement Growth Amid Innovation‑Drug Volatility
Chongqing Lummy Pharmaceutical navigates volatile innovation‑drug market swings, leveraging new 2026 drug catalogue coverage and diversified portfolio for future growth.
4 minutes to read
